WallStreetZenWallStreetZen

NASDAQ: DYN
Dyne Therapeutics Inc Stock Ownership - Who owns Dyne Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Dyne Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John CoxCEO President2025-09-052,640$13.41
$35.40kSell
Douglas KerrChief Medical Officer2025-09-05873$13.41
$11.71kSell
Johanna FriedlnadererChief Commercial Officer2025-09-05144$13.41
$1.93kSell
Douglas KerrChief Medical Officer2025-09-043,552$13.27
$47.14kSell
Johanna FriedlnadererChief Commercial Officer2025-09-04894$13.27
$11.86kSell
John CoxCEO President2025-07-14100,000$9.11
$911.00kBuy
John CoxCEO President2025-06-054,060$13.35
$54.20kSell
Douglas KerrChief Medical Officer2025-06-051,342$13.35
$17.92kSell
Johanna FriedlnadererChief Commercial Officer2025-06-05146$13.35
$1.95kSell
Johanna FriedlnadererChief Commercial Officer2025-03-13143$12.12
$1.73kSell

1 of 7

DYN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DYN insiders and whales buy or sell their stock.

DYN Shareholders

What type of owners hold Dyne Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP6.83%9,714,392$127.74MInstitution
Janus Henderson Group PLC6.63%9,437,962$124.11MInstitution
Atlas Venture Life Science Advisors LLC6.42%9,130,465$120.07MInstitution
Blackrock Inc5.68%8,078,428$106.23MInstitution
Vanguard Group Inc5.38%7,651,157$100.61MInstitution
Atlas Venture Fund XI LP4.61%6,562,578$86.30MInsider
Forbion Capital Fund IV Cooperatief Ua4.31%6,131,079$80.62MInsider
Fcpm III Services Bv3.84%5,462,846$71.84MInstitution
Fmr LLC3.72%5,293,369$69.61MInstitution
Siren LLC3.40%4,836,437$63.60MInstitution

1 of 3

DYN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DYN80.45%19.55%Net BuyingNet Buying
HRMY77.56%22.44%Net SellingNet Selling
MESO0.27%0.00%
ADPT62.48%37.52%Net Selling
IMCR95.69%4.31%Net BuyingNet Buying
View Top Biotech Stocks

Dyne Therapeutics Stock Ownership FAQ

Who owns Dyne Therapeutics?

Dyne Therapeutics (NASDAQ: DYN) is owned by 90.41% institutional shareholders, 21.97% Dyne Therapeutics insiders, and 0.00% retail investors. Atlas Venture Fund XI LP is the largest individual Dyne Therapeutics shareholder, owning 6.56M shares representing 4.61% of the company. Atlas Venture Fund XI LP's Dyne Therapeutics shares are currently valued at $86.30M.

If you're new to stock investing, here's how to buy Dyne Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.